![]()
|
|
||||||||
J Biol Chem, Vol. 273, Issue 15, 8875-8881, April 10, 1998
,
,
§, and
From the Departments of NADH:cytochrome b5
reductase activates the mitomycins to alkylating intermediates in
vitro. To investigate the intracellular role of this enzyme in
mitomycin bioactivation, Chinese hamster ovary cell transfectants
overexpressing rat NADH:cytochrome b5 reductase
were generated. An NADH:cytochrome b5
reductase-transfected clone expressed 9-fold more enzyme than did
parental cells; the levels of other mitomycin-activating
oxidoreductases were unchanged. Although this enzyme activates the
mitomycins in vitro, its overexpression in living cells
caused decreases in sensitivity to mitomycin C in air and decreases in
sensitivity to porfiromycin under both air and hypoxia. Mitomycin C
cytotoxicity under hypoxia was similar to parental cells. Because
NADH:cytochrome b5 reductase resides predominantly in the mitochondria of these cells, this enzyme may
sequester these drugs in this compartment, thereby decreasing nuclear
DNA alkylations and reducing cytotoxicity. A cytosolic form of
NADH:cytochrome b5 reductase was generated.
Transfectants expressing the cytosolic enzyme were restored to parental
line sensitivity to both mitomycin C and porfiromycin in air with
marked increases in drug sensitivity under hypoxia. The results
implicate NADH:cytochrome b5 reductase in
the differential bioactivation of the mitomycins and indicate
that the subcellular site of drug activation can have complex effects
on drug cytotoxicity.
Pharmacology and
§ Therapeutic Radiology and Developmental Therapeutics
Program, Yale Cancer Center, Yale University School of Medicine,
New Haven, Connecticut 06520
This article has been cited by other articles:
![]() |
H. A. Seow, P. G. Penketh, K. Shyam, S. Rockwell, and A. C. Sartorelli PNAS, June 28, 2005; 102(26): 9282 - 9287. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. H. Ward, S. Danson, A. T. McGown, M. Ranson, N. A. Coe, G. C. Jayson, J. Cummings, R. H.J. Hargreaves, and J. Butler Preclinical Evaluation of the Pharmacodynamic Properties of 2,5-Diaziridinyl-3-Hydroxymethyl-6-Methyl-1,4-Benzoquinone Clin. Cancer Res., April 1, 2005; 11(7): 2695 - 2701. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Seow, M. F. Belcourt, P. G. Penketh, W. F. Hodnick, M. Tomasz, S. Rockwell, and A. C. Sartorelli Nuclear Localization of NADPH:Cytochrome c (P450) Reductase Enhances the Cytotoxicity of Mitomycin C to Chinese Hamster Ovary Cells Mol. Pharmacol., February 1, 2005; 67(2): 417 - 423. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Seow, P. G. Penketh, M. F. Belcourt, M. Tomasz, S. Rockwell, and A. C. Sartorelli Nuclear Overexpression of NAD(P)H:Quinone Oxidoreductase 1 in Chinese Hamster Ovary Cells Increases the Cytotoxicity of Mitomycin C under Aerobic and Hypoxic Conditions J. Biol. Chem., July 23, 2004; 279(30): 31606 - 31612. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Holtz, S. Rockwell, M. Tomasz, and A. C. Sartorelli Nuclear Overexpression of NADH:Cytochrome b5 Reductase Activity Increases the Cytotoxicity of Mitomycin C (MC) and the Total Number of MC-DNA Adducts in Chinese Hamster Ovary Cells J. Biol. Chem., February 7, 2003; 278(7): 5029 - 5034. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Belcourt, P. G. Penketh, W. F. Hodnick, D. A. Johnson, D. H. Sherman, S. Rockwell, and A. C. Sartorelli Mitomycin resistance in mammalian cells expressing the bacterial mitomycin C resistance protein MCRA PNAS, August 31, 1999; 96(18): 10489 - 10494. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G. Penketh, W. F. Hodnick, M. F. Belcourt, K. Shyam, D. H. Sherman, and A. C. Sartorelli Inhibition of DNA Cross-linking by Mitomycin C by Peroxidase-mediated Oxidation of Mitomycin C Hydroquinone J. Biol. Chem., September 7, 2001; 276(37): 34445 - 34452. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |